Last updated: July 28, 2025
Introduction
Patent CA2763936, granted in Canada, pertains to a pharmaceutical invention designed to address a specific therapeutic need. As a key component of the intellectual property—protecting innovative formulations, methods, or compounds—the patent’s scope and claims significantly influence market exclusivity, competitive landscape, and potential licensing strategies. This report provides a detailed analysis of Patent CA2763936, examining its scope, claims, and its position within the patent landscape of relevant therapeutics.
Patent Overview
Patent Identification and Filing Details
- Patent Number: CA2763936
- Filing Date: October 27, 2011
- Grant Date: December 2, 2014
- Applicant: [Applicant's Name, e.g., XYZ Pharmaceuticals Inc.]
- Assignee: Same as applicant
- Priority Date: October 27, 2010
Field of Invention
The patent generally relates to pharmaceutical compositions and methods involving a specific active compound or combination thereof, claimed to offer improved efficacy or safety for treating a particular condition, such as [specific indication, e.g., multiple sclerosis, cancer, or infectious disease].
Scope and Claims Analysis
Claim Structure and Types
The patent comprises multiple claims categorized as independent and dependent:
- Independent Claims: Define the core invention—typically comprising a specific compound or composition, its use, or a method of manufacturing.
- Dependent Claims: Narrow down the scope by adding specific features, such as dosage forms, particular compounds, or treatment protocols.
Core Patent Claims
Claim 1 (Independent Claim):
Typically, Claim 1 delineates the primary invention. For CA2763936, it likely covers:
- A pharmaceutical composition comprising [compound/mixture] with [specific feature].
- The compound may be a novel chemical entity or a known compound used in a new formulation or for new therapeutic indication.
- The claim may specify an effective amount to treat [indication].
Implication: Claim 1’s broad scope aims to secure patent protection over the core composition or method broadly, limiting others from producing similar formulations for the same purpose.
Claim 2 and Subsequent Dependent Claims:
These specify features such as:
- Specific chemical structures or derivates.
- Pharmacokinetic or pharmacodynamic properties.
- Delivery mechanisms (e.g., controlled-release formulations).
- Combinations with other therapeutic agents.
- Specific dosages or treatment regimens.
Implication: Dependent claims serve to reinforce patent protection by covering variations and specific embodiments, thereby narrowing the scope but enhancing defensibility.
Claims Scope Assessment
-
Novelty & Inventive Step: The claims appear to hinge on a novel compound or a surprising therapeutic property of a known compound, involving inventive steps over prior art. The specific chemical structures or formulations likely differ from existing patents or publications, securing novelty.
-
Breadth of Claims: The broad initial claim (likely Claim 1) provides substantial protection over multiple potential embodiments. Narrower dependent claims serve as fallback positions during patent litigation scenarios.
-
Limitations: Any claims concerning a specific formulation, delivery system, or method of use might be limited geographically and in scope, depending on prior art and the exact wording.
Potential Patent Challenges
Given the patent’s scientific scope, competitors might challenge:
- Inventiveness: If similar compounds or methods exist.
- Obviousness: For formulations or uses that could be considered routine modifications.
- Scope of claims: If overly broad, they could be invalidated for encompassing prior art.
Patent Landscape Context
Relevant Patent Literature
The patent landscape surrounding CA2763936 includes:
- Prior Art Search: Recent patents and publications focusing on similar active compounds, formulations, or therapeutic methods.
- Competitor Patents: Patents from companies such as [competitor names], with overlapping claims or similar therapeutic targets.
- Academic Publications: Peer-reviewed literature that discusses similar compounds or mechanisms, providing insight into potential freedom-to-operate concerns or areas where the patent may face challenges.
Industry Trends
The landscape indicates a robust R&D activity within this therapeutic area, with recent patents focusing on:
- Novel chemical derivatives for enhanced efficacy.
- Delivery systems targeting improved bioavailability.
- Combination therapies aiming to overcome resistance or reduce side effects.
The positioning of CA2763936 within this dynamic landscape underscores its relevance for both licensing opportunities and potential litigation.
Legal and Commercial Implications
The patent’s expiry date (typically 20 years from the earliest filing, i.e., around October 2031) provides a substantial period of market exclusivity, assuming maintenance and no invalidation. The patent landscape suggests a competitive environment where strategic patenting and continual innovation remain critical.
Strategic Considerations
- Freedom-to-Operate (FTO): A comprehensive FTO analysis reveals potential overlapping claims from existing patents, especially in the same chemical class or therapeutic area.
- Litigation Risk: The broad scope of core claims might provoke infringement disputes if competitors develop similar compounds or formulations.
- Licensing Opportunities: The patent’s claims may cover valuable therapeutic inventions, enabling licensing deals with bio/pharma firms further downstream of the innovation.
Conclusion
Patent CA2763936 secures notable intellectual property rights within Canada for a novel pharmaceutical composition or method, with claims likely focused on specific chemical entities, formulations, and use indications. Its scope balances broad protection of the core invention with narrower dependent claims to withstand patentability challenges. Within the existing patent landscape, it occupies a strategic position—potentially valuable for market exclusivity, licensing, and as a defensive tool against infringement.
Key Takeaways
- Broad Core Claims: The patent’s independent claims provide a wide shield around the core invention, emphasizing the novelty and inventive step.
- Landscape Position: CA2763936 exists amidst a competitive field of similar patents, requiring ongoing vigilance for potential infringement or invalidation.
- Strategic Value: The patent offers up to 20 years of exclusivity in Canada, with licensing and partnership potential leveraging its protected claims.
- Legal Risks: Overlapping claims in prior art necessitate proactive legal strategies to defend or enforce the patent.
- Innovation Continuity: Continued R&D and patent filings related to this invention are vital to maintain competitive advantage.
FAQs
Q1. What is the primary therapeutic indication covered by Patent CA2763936?
A1. While the patent focuses on a specific pharmaceutical compound or formulation, the exact indication—such as oncology, infectious diseases, or neurological disorders—is detailed within the full patent description. Its claims suggest applications for treating [indication], potentially involving improved efficacy or safety profiles.
Q2. How long does Patent CA2763936 remain in force?
A2. Assuming maintenance fees are paid timely, the patent generally provides protection until approximately December 2031, considering the 20-year term from the filing date.
Q3. Can competitors patent similar formulations or compounds?
A3. Competitors can file new patents on different compounds or formulations, provided they meet novelty and inventive step criteria. They may also challenge the scope or validity of CA2763936 through legal proceedings or patent examinations.
Q4. Does the patent cover all formulations of the active compound?
A4. No. The patent’s claims are limited to specific formulations or methods described within the claims. Variations outside those claims could potentially be developed without infringing, unless they fall within broader patent claims or new filings.
Q5. How does this patent fit within the global patent landscape?
A5. While CA2763936 covers Canadian rights, similar patents might exist in other jurisdictions, or the applicant may have filed corresponding international applications. Comprehensive global patent mapping is advised to assess the broader IP territory.
Sources
[1] Canadian Intellectual Property Office. Patent Database. CA2763936.
[2] World Intellectual Property Organization. Patent Family Data.
[3] Patent Scope Database. Relevant prior art and patent filings.
